Daily Chart: the COVID-19 pipeline by therapeutic class

Immunosuppressants top antivirals for the most common therapeutic class among molecules in development for COVID-19.

Many of the immunosuppressants are repurposed agents that are being tested in severe patients, in whom excess inflammation is thought to drive respiratory distress (see “Closing in on Matching Therapeutic Mechanism to Disease Stage”). ...